Unknown

Dataset Information

0

The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers.


ABSTRACT: In most cases, acute diarrhoea will become self-limiting during the first few days after onset. For young children, however, health risks may develop when the disease lasts longer than 3 days. The purpose of the present trial was to determine whether the stool frequency of infants and toddlers suffering from acute diarrhoea could be normalised more quickly by administering the probiotic Escherichia coli Nissle 1917 (EcN) solution than by administering a placebo. The safety of EcN were also assessed. A total of 113 children (aged 2-47 months) with acute diarrhoea (> three watery or loose stools in 24 h) were randomised to either a group receiving the probiotic EcN suspension (n = 55) or a group receiving the placebo suspension (n = 58) in a confirmative, double-blind clinical trial. Depending on the age of patients, 1-3 ml per day of verum suspension (10(8) viable EcN cells per millilitre) or placebo were administered orally. The causes of the diarrhoea were viral rather than bacterial, but they were mainly unspecific infections. The median onset of treatment response (reduction of daily stool frequency to

SUBMITTER: Henker J 

PROVIDER: S-EPMC1802727 | biostudies-literature | 2007 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers.

Henker Jobst J   Laass Martin M   Blokhin Boris M BM   Bolbot Yuriy K YK   Maydannik Vitaliy G VG   Elze Martina M   Wolff Corinna C   Schulze Jürgen J  

European journal of pediatrics 20070208 4


In most cases, acute diarrhoea will become self-limiting during the first few days after onset. For young children, however, health risks may develop when the disease lasts longer than 3 days. The purpose of the present trial was to determine whether the stool frequency of infants and toddlers suffering from acute diarrhoea could be normalised more quickly by administering the probiotic Escherichia coli Nissle 1917 (EcN) solution than by administering a placebo. The safety of EcN were also asses  ...[more]

Similar Datasets

| S-EPMC5987069 | biostudies-literature
| S-EPMC7215827 | biostudies-literature
| S-EPMC490877 | biostudies-literature
| S-EPMC5670229 | biostudies-literature
| S-EPMC3495787 | biostudies-literature
2018-06-14 | GSE109932 | GEO
| S-EPMC8386472 | biostudies-literature
2013-12-19 | PXD000367 | Pride
| S-EPMC6776366 | biostudies-literature
| S-EPMC6062509 | biostudies-literature